The third edition of EU TalentOn closed with the announcement of its winning teams on 11 September in Brest, France. Over five days, 100 early-career researchers aged 21 to 35 of 43 different nationalities, worked in teams to develop concrete responses to some of Europe's most pressing challenges, based on the five EU Missions under Horizon Europe.

The participants competed for a share of an €80,000 prize pool. First and second prizes were awarded in each of the five categories, alongside an Alumni Prize, a Special Jury Prize and the overall Grand Jury Prize.

The teams winning the 1^st prize were:

• Adaptation to climate change: Alejandro Roman, Marie Johanna Univer, Edoardo Kimani Bellotto and Florin Miron won with IMPRREST - from big data to decisions, a tool that gives responders one verified assessment of climate emergencies and evidence for adaptation.
• Cancer: Xhilda Dhamo, Oliwia Kosecka and Jafar Gura won with CogniVoice - a patient centered speech monitoring platform for post-treatment surveillance of Brain Cancer.
• Restore our Ocean and Waters Mission: Gabriel Tejero, Siddhanth Shishodia, Dominika Czekanowska and Gjylije Hoti won with Mission PFASSible – a solution that helps with pollution removal into verified risk reduction: sensing, capturing, concentrating, and proving water safety. 
• Climate-neutral and smart cities: Lucia Petronio, Samar Momin, Samira Huber and Imen Kaabachi won with Block2City - turning building data into renovation choices, funding guidance and expert handoff, while helping cities map local demand.
• Soil: Natasha Waris, Ilaria Bertolini, Felipe Quiroz, and Victoria Boycheva, won with RhizoSentinel – a solution that turns plants into living soil biosensors that reveal hidden soil biological threats before they cause crop losses, enabling earlier intervention and smarter soil management.
• The Grand Jury Prize of €12,000 for the best overall project went to RhizoSentinel, while the Special Jury Prize of €3,000 was awarded to Marion Le Meur, Narjes Yazdi, Suresh Ajmeera, and Alberto Galindo Caballero with their project Colospy - a rapid, saliva-based molecular test detecting colorectal-cancer-miRNA signature, designed as a stool-free screening option.

The projects were assessed by a jury of experts from academia, business and government on both scientific merit and market potential – the ability to become real innovations that would contribute to Europe's competitiveness.

Startups, Research and Innovation Commissioner Ekaterina Zaharieva (pictured) said:

“Congratulations to the winners of EU TalentOn 2026. The solutions you have put forward show what European talent can achieve when it is given room to think differently. Results like these underline that Europe's most important asset are its brightest minds.”

Background

EU TalentOn brings together early-career researchers to develop solutions to major societal challenges linked to the five EU Missions under Horizon Europe. By bringing science closer to citizens and building new connections between science and society in open, playful and engaging ways, it supports the objectives of the ERA Policy Agenda. 

EU TalentOn is a flagship event of Science Comes to Town, the Commission's year-long initiative bringing research and innovation closer to citizens across three host cities in 2026: Kiel (Germany), Brest (France) and Split (Croatia). With over more than 1,000 activities and with more than 70 partners, Science Comes to Town 2026 is connecting scientific institutions, innovation ecosystems and the public throughout the year.

The programme continues later this month, when Kiel hosts the 36th EU Contest for Young Scientists (EUCYS 2026) from 22 to 27 September, before Science Comes to Town 2026 draws to a close with a joint Closing Event and Ceremony on 14–16 December.

Science Comes to Town will return for a second edition in 2027, hosted by four new cities: Aarhus (Denmark), Genoa (Italy), Kaunas (Lithuania) and Oeiras (Portugal). EU TalentOn 2027 will be held in Kaunas, while EUCYS 2027 will take place in Genoa.

Women accounted for 54% of participants in the 2026 edition, reflecting the growing contribution of female talent to Europe’s research and innovation landscape.

More information

• EU TalentOn 2026
• Science Comes to Town

Drugs such as morphine and fentanyl act on opioid receptors throughout the body and central nervous system.

The post Scientists find brain switch that could help turn off chronic pain appeared first on BOL News.

In this edition: Bad medicine, imperfect sound forever, know when to fold ’em, brainiacs, and a call of the wild.

Scientists are growing miniature human brains in labs around the world. (Yep, you read that right.) For Wired, Claire L. Evans reports on the latest research in the field of organoid intelligence, or OI, where scientists are artificially growing brain organoids from tiny human samples, whether skin, blood, teeth, or even hair. As these seed-sized globs mature, they are able to send and receive electrical signals, and even learn to remember and anticipate them. In other words, this living matter is programmable. “And this is where things get truly weird,” writes Evans.

For now, these neural computers are mostly of interest to researchers who want to work with neurons without taking on the tedious wet-lab husbandry themselves. Eventually, however, the company hopes that neurons will prove themselves to be an energy-efficient, resilient substrate for more general computing applications—including some tasks currently handled by AI, like image recognition and classification.

“When you think about what you want from AI, it’s biology,” said Brett Kagan, Cortical Labs’ chief operating officer, when I reached him over Zoom. “You want it to be self-repairing as much as possible. You want it to be adaptable. You want it to be long-lived. You want it to be energy-efficient. These are all features you get for free in biology.”

In this harrowing, incredibly reported story co-published by Science and Retraction Watch, Brendan Borrell uncovers how “Mei,” a 6-year-old girl in China, died a week after an experimental gene-editing trial went wrong—and how her medical team, led by neuroscientist Zilong Qiu, downplayed the risks to her parents, did not publicly disclose her death, and has faced no real accountability.

On 23 March 2025, the day before the procedure, the family settled into a shared room inside a crowded pediatric ward. When the other girl in the room broke into tears, Mei handed her one of her favorite stuffed animals: a blue bird. “She liked to give things to other kids,” Jason said.

The next day Mei put on a brave face as she was taken to the procedure room. Yu’s handpicked doctor inserted a needle between two vertebrae on her lower back and withdrew just over a teaspoon of spinal fluid to create space for the drug. Then, he swapped syringes and gently pressed down on the plunger, filling her spinal canal with viruses.

The Director of National Intelligence has revealed the existence of more than 120 U.S.-funded biological laboratories in over 30 countries, including several dozen in Ukraine. This revelation has reignited the debate on transparency and biosafety.

Today, on my final day as Director of National Intelligence, I’m releasing never-before-seen communications and documents exposing how Dr. Fauci provided millions in US taxpayer dollars to fund dangerous gain-of-function research at the Wuhan lab, worked with politicized elements… pic.twitter.com/ZMdliW4zyS

— DNI Tulsi Gabbard (@DNIGabbard) June 19, 2026

An unprecedented report made public

After several months of reviewing intelligence archives, Director of National Intelligence (DNI) Tulsi Gabbard released new information indicating that the United States has long funded more than 120 biolaboratories in over 30 countries.

Gabbard described the release as one of her final actions before leaving her post as Director of National Intelligence. On May 22, she announced her resignation in order to care for her husband, who has been diagnosed with cancer.

The declassified documents, which remain partially redacted, detail the locations and functions of various laboratories that “likely housed dangerous pathogens.”

Highly Dangerous Pathogens, Limited Oversight

According to the documents, the United States “built and supported” 40 biolabs in Ukraine that worked on “particularly dangerous pathogens,” including anthrax, avian influenza, Ebola, plague, and tuberculosis. At least 12 of these laboratories conducted research involving human subjects.

According to an official ODNI statement, “many of these U.S.-government-funded biolabs conducted research on dangerous and highly contagious pathogens, in some cases including studies designed to enhance the functions of these pathogens, with virtually no oversight or supervision.”

The declassified map notably shows that a laboratory in Odesa—a city of one million residents—stored biological agents inherited from the former Soviet biological weapons program, including anthrax, tuberculosis, SARS, Marburg virus, Ebola, Lassa fever, and plague.

Risks in a War Zone Highlighted

Gabbard emphasized that some of these laboratories in Ukraine could be compromised because of the ongoing conflict with Russia. According to her, intelligence agencies had previously warned internally that a U.S.-linked biolaboratory in Ukraine “likely housed dangerous pathogens” and remained vulnerable to Russian attack, seizure, or damage.

Previous Administrations Accused

In a statement, Gabbard said that Dr. Fauci and members of the Biden administration’s national security team “lied to the American people about the existence of U.S.-funded and U.S.-supported biolaboratories and threatened those who attempted to expose the truth.”

The ODNI stated that this information had been “intentionally concealed” by previous administrations.

In March 2022, Under Secretary of State Victoria Nuland acknowledged under oath that “Ukraine has biological research facilities,” while denying that those facilities worked on biological weapons and asserting that “the United States does not own or operate any chemical or biological laboratories in Ukraine.”

End of Funding for High-Risk Research

Gabbard also confirmed a major policy shift under the Trump administration: Washington is ending decades of federal funding for gain-of-function research overseas. The move follows Executive Order 14292, signed by President Trump in May 2025, which aimed to terminate such international funding.

What the Report Does Not Prove

It should be noted that the declassified documents, while exposing serious shortcomings in oversight, risky gain-of-function research, and vulnerabilities in conflict zones, concern programs many of which supported legitimate disease surveillance efforts. The report does not confirm the existence of an illegal offensive biological weapons program, but it does document a striking lack of transparency and oversight spanning several decades.

Sources: ODNI (Official Release No. 10-26, June 12, 2026), Newsweek, Daily Caller, and BizPac Review.

The documents

 

 

L’article U.S. biolabs abroad: Tulsi Gabbard declassifies an explosive report est apparu en premier sur FrenchDailyNews.